Salmeterol/fluticasone combination in the treatment of COPD.

Authors:
Chung KF.

Journal:
Int J Chron Obstruct Pulmon Dis

Publication Year: 2006

PMCID:
PMC2707153

PMID:
18046860

View on PubMed View on PMC
Journal Information

Full Title: Int J Chron Obstruct Pulmon Dis

Abbreviation: Int J Chron Obstruct Pulmon Dis

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Pulmonary Medicine

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Abhd2, a Candidate Gene Regulating Airway Remodeling in COPD via TGF-β.
Lv MY; Jin LL; Sang XQ and 4 more (2024) - Transparency Score: 3/6
Acute Exacerbation and Longitudinal Lung Function Change of Preserved Ratio Impaired Spirometry.
Yoon SM; Jin KN; Lee HJ and 5 more (2024) - Transparency Score: 3/6
Acute Exacerbation of Chronic Obstructive Pulmonary Disease Due to Carbapenem-Resistant <i>Klebsiel…
Ouyang P; Zhou Z; Pan C and 5 more (2024) - Transparency Score: 2/6
Addressing Barriers to Chronic Obstructive Pulmonary Disease (COPD) Care: Three Innovative Evidence…
Siu DCH; Gafni-Lachter L. (2024) - Transparency Score: 2/6
ApoA1, ApoB, ApoA1/B for Pathogenic Prediction of Chronic Obstructive Pulmonary Disease Complicated…
Meng J; Yang W; Chen Z and 4 more (2024) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
1/6
0.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Disclosures: KFC has received honoraria for participating in Advisory Board meetings for GSK, Astra-Zeneca, Novartis, Altana, and Celgene, and research grants from GSK, Novartis, and Scios."

Funding Disclosure
Protocol Registration
Open Access
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025